Finance

Beta
Lists
019175:KRX
Shinpoong Pharmaceutical Co Ltd Preference Shares
₩14,250.00
-0.70%
(-100.00) 1D
Jun 5, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 019175...
Open
₩14,350
High
₩14,370
Low
₩14,020
Mkt. cap
506.33B
Avg. vol.
7.15K
Volume
4.49K
P/E ratio
73.80
52-wk high
₩55,000
52-wk low
₩13,500
EPS
₩193
Shares outstanding
1.99M
No. of employees
809
Open
₩14,350
High
₩14,370
Low
₩14,020
Mkt. cap
506.33B
Avg. vol.
7.15K
Volume
4.49K
P/E ratio
73.80
52-wk high
₩55,000
52-wk low
₩13,500
EPS
₩193
Shares outstanding
1.99M
No. of employees
809
News stories
From sources across the web
About Shinpoong Pharmaceutical Co Ltd Preference Shares
CEOYoo Je-man
Employees809
Founded1962
Headquarters-
SectorPharmaceutical industry
Websiteshinpoong.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
58.62B
62.61B
58.04B
54.53B
Cost of goods sold
31.33B
33.91B
33.04B
33.12B
Cost of revenue
31.33B
33.91B
33.04B
33.12B
Research and development expenses
2.50B
2.39B
1.77B
4.19B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.83B
18.41B
19.16B
18.01B
Operating expense
22.36B
21.48B
21.14B
21.77B
Total operating expenses
53.68B
55.39B
54.17B
54.89B
Operating income
4.94B
7.22B
3.87B
-363.22M
Other non operating income
31.61M
37.58M
56.74M
-42.52M
EBT including unusual items
2.35B
7.26B
302.61M
439.87M
EBT excluding unusual items
2.32B
7.26B
3.25B
423.63M
Income tax expense
-434.02M
847.52M
-147.88M
70.67M
Effective tax rate
-18.48%
11.67%
-48.87%
16.07%
Other operating expenses
183.68M
43.68M
-434.64M
105.86M
Net income
3.27B
6.38B
461.37M
358.51M
Net profit margin
5.58%
10.19%
0.79%
0.66%
Earnings per share
-
-
-
-
Interest and investment income
191.58M
208.75M
200.34M
246.20M
Interest expense
-656.08M
-642.57M
-671.63M
-862.72M
Net interest expenses
-464.50M
-433.82M
-471.28M
-616.52M
Depreciation and amortization charges
354.46M
528.97M
372.83M
362.48M
EBITDA
7.73B
10.17B
6.67B
2.42B
Gain or loss from assets sale
-702.00K
-19.00K
-1.82M
-12.35M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer